Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Precision BioSciences Stock (ISIN: US74019P1084) Surges on Q4 Profit Turnaround Amid Analyst Upgrade
Precision BioSciences (NASDAQ: DTIL) reported a significant turnaround in Q4 2025, posting a $19.2 million profit on $34.2 million revenue, a major shift from previous losses. This positive financial report has led Wall Street Zen to upgrade the stock from Sell to Hold, with analysts projecting a 599% upside potential from current levels. The company’s proprietary ARCUS gene editing platform and operational improvements are credited for this performance, attracting attention from both US and European investors.